Human Breast Cancer Tissue Lysates

Pricing
Normal Lysates:  $125/100 ug
Tumor Lysates:   $175/100 ug
Nor./Tum. set: $270.00 (10% off)
Discounts
2-8    Vials  10%
9-20  Vials  15%
>20   Vials  20%

Call, Fax, or Email Your Order!

Introduction:

The following is a list of breast cancer histologic classifications. Infiltrating or invasive ductal cancer is the most common breast cancer histologic type and comprises 70% to 80% of all cases.

Carcinoma, NOS (not otherwise specified).

Ductal - Intraductal (in situ), Invasive with predominant Intraductal component, Invasive, NOS, Comedo (Inflammatory, Medullary with lymphocytic infiltrate, Mucinous (colloid), Papillary, Scirrhous, Tubular, Other).

Lobular - In situ, Invasive with predominant in situ component, Invasive.

Nipple - Pagetís disease, Pagetís disease with intraductal carcinoma, Pagetís disease with invasive ductal carcinoma.

Other - Undifferentiated carcinoma.

The following are tumor subtypes that occur in the breast but are not considered to be typical breast cancers - Cystosarcoma phyllodes, Angiosarcoma, Primary lymphoma.

Human Breast Cancer Tissue Lysates

Catalog Number

Diagnosis

Grade

Stage

TNM

Sex

Age

T2-001

Ductal Carcinoma

2

IIA

T2N0M0

F

54

T2-002

Ductal Carcinoma

2

IIIB

T2N1M0

F

36

T2-003

Ductal Carcinoma

2

IV

T4N2Mx

F

61

T2-004

Ductal Carcinoma

2

II

T2N0Mx

F

72

T2-005

Ductal Carcinoma

2

IV

T4N2Mx

F

45

T2-006

Ductal Carcinoma

2

IIA

T2N0M0

F

42

T2-007

Ductal Carcinoma

2

IIB

T2N1M0

F

44

T2-008

Ductal Carcinoma

2

IIB

T2N1M0

F

39

T2-009

Ductal Carcinoma

2

IIIB

T4bN1M0

F

54

T2-010

Ductal Carcinoma

2

IIB

T2N1M0

F

54

T2-011

Ductal Carcinoma

2

IIB

T3N0M0

F

46

T2-012

Ductal Carcinoma

2

IIIB

T4bN2M0

F

55

T2-013

Ductal Carcinoma

2

IIB

T2N1M0

F

44

T2-014

Ductal Carcinoma

2

IIB

T2N1M0

F

63

T2-015

Ductal Carcinoma

2

IIB

T2N1M0

F

61

T2-016

Ductal Carcinoma

2

IIA

T1N1M0

F

61

T2-017

Ductal Carcinoma

2

IV

T4N1Mx

F

85

T2-018

Ductal Carcinoma

2

IV

T4N0M0

F

75

T2-019

Ductal Carcinoma

2

II

T2NxMx

F

47

T2-020

Ductal Carcinoma

3

IIA

T2N0M0

F

43

T2-021

Ductal Carcinoma

3

IIB

T2N1M0

F

61

T2-022

Ductal Carcinoma

3

IIB

T2N1M0

F

39

T2-023

Ductal Carcinoma

3

II

T2N1Mx

F

35

T2-024

Ductal Carcinoma

3

III

T3N1bMx

F

73

T2-025

Ductal Carcinoma

3

IIB

T2N1M0

F

50

T2-026

Ductal Carcinoma

3

IIIA

T3N1M0

F

52

T2-027

Ductal Carcinoma

3

IIIA

T3N1M0

F

49

T2-028

Ductal Carcinoma

3

II

T2NxM0

F

41

T2-029

Ductal Carcinoma

3

IV

T4N1M0

F

47

T2-030

Ductal Carcinoma

3

II

T2N1M0

F

55

T2-031

Ductal Carcinoma

3

II

T2N0M0

F

75

T2-032

Ductal Carcinoma

3

II

T2N1M0

F

53

T2-033

Ductal Carcinoma

3

II

T2N1M0

F

60

T2-034

Ductal Carcinoma

3

IV

T4N2Mx

F

54

T2-035

Ductal Carcinoma

3

II

T2N1M0

F

43

T2-036

Ductal Carcinoma

3

II

T2N1Mx

F

53

T2-037

Ductal Carcinoma

3

III

T3N2M0

F

43

T2-038

Ductal Carcinoma

3

II

T2N1M0

F

58

T2-039

Mucinous Carcinoma

1

II

T2N1Mx

F

51

T2-040

Ductal Carcinoma

2

IIIB

T4bN2M0

F

48

T2-041

Ductal Carcinoma

2

IIIA

T3N2M0

F

42

T2-042

Ductal Carcinoma

2

II

T2NxM0

F

37

T2-043

Ductal Carcinoma

1

IIB

T2N1M0

F

51

T2-044

Ductal Carcinoma

1

IIIA

T3N1M0

F

47

T2-045

Ductal Carcinoma

1

IIIA

T3N1M0

F

38

T2-046

Ductal Carcinoma

1

IIA

T2N0M0

F

60

T2-047

Ductal Carcinoma

2

IIB

T2N1M0

F

32

T2-048

Ductal Carcinoma

1

IIB

T2N1M0

F

39

T2-049

Mucinous Carcinoma

2

IIIA

T3N1M0

F

43

T2-050

Lobular Carcinoma

n/a

III

T3N2M0

F

39

T2-051

Ductal Carcinoma

3

III

T3N2M0

F

44

T2-052

Mucinous Carcinoma

n/a

IB

T2N0Mx

F

59

T2-053

Metaplastic Carcinoma

3

IV

T4N1bMx

F

46

T2-054

Intraductal Carcinoma

2

IIA

T2N0M0

F

41

T2-055

Intraductal Carcinoma

2

IIB

T2N1M0

F

40

T2-056

Intraductal Carcinoma

2

IIA

T2N0M0

F

50

 

References:

Breast. In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer, 2002., pp 171-180.

Yeatman TJ, Cantor AB, Smith TJ, et al.: Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222 (4): 549-59; discussion 559-61, 1995.

Chaney AW, Pollack A, McNeese MD, et al.: Primary treatment of Cystosarcoma phyllodes of the breast. Cancer 89 (7): 1502-11, 2000.